RIPK1 and pancreatic neoplasm: However, variations of RIPK1 was not associated with pancreatic cancer risk in a Canada population, or with risk for non-Hodgkin’s lymphoma in a Caucasian population residing in Minnesota, Iowa, or Wisconsin [30, 31].